These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 9142376)

  • 1. An immunoassay for anti-neuronal antibodies associated with involuntary repetitive movement disorders.
    Laurino JP; Hallett J; Kiessling LS; Benson M; Pelletier T; Kuhn C
    Ann Clin Lab Sci; 1997; 27(3):230-5. PubMed ID: 9142376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibodies against a neuron-like (HTB-10 neuroblastoma) cell in children with Tourette syndrome.
    Singer HS; Giuliano JD; Hansen BH; Hallett JJ; Laurino JP; Benson M; Kiessling LS
    Biol Psychiatry; 1999 Sep; 46(6):775-80. PubMed ID: 10494445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antineuronal antibodies in movement disorders.
    Kiessling LS; Marcotte AC; Culpepper L
    Pediatrics; 1993 Jul; 92(1):39-43. PubMed ID: 8516083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum autoantibodies do not differentiate PANDAS and Tourette syndrome from controls.
    Singer HS; Hong JJ; Yoon DY; Williams PN
    Neurology; 2005 Dec; 65(11):1701-7. PubMed ID: 16207842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antineural antibody in patients with Tourette's syndrome and their family members.
    Yeh CB; Wu CH; Tsung HC; Chen CW; Shyu JF; Leckman JF
    J Biomed Sci; 2006 Jan; 13(1):101-12. PubMed ID: 16215701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperpolarisation-activated cyclic nucleotide channel 4 (HCN4) involvement in Tourette's syndrome autoimmunity.
    Yeh CB; Shui HA; Chu TH; Chen YA; Tsung HC; Shyu JF
    J Neuroimmunol; 2012 Sep; 250(1-2):18-26. PubMed ID: 22683190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble adhesion molecules in Gilles de la Tourette's syndrome.
    Martino D; Church AJ; Defazio G; Dale RC; Quinn NP; Robertson MM; Livrea P; Orth M; Giovannoni G
    J Neurol Sci; 2005 Jul; 234(1-2):79-85. PubMed ID: 15941572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum autoantibodies measured by immunofluorescence confirm a failure to differentiate PANDAS and Tourette syndrome from controls.
    Morris CM; Pardo-Villamizar C; Gause CD; Singer HS
    J Neurol Sci; 2009 Jan; 276(1-2):45-8. PubMed ID: 18823914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoimmune mechanisms in movement disorders.
    Visvanathan K; Trifiletti RR; Altemus M; Zabriskie JB
    Semin Pediatr Neurol; 2000 Jun; 7(2):103-7. PubMed ID: 10914411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies against neural, nuclear, cytoskeletal, and streptococcal epitopes in children and adults with Tourette's syndrome, Sydenham's chorea, and autoimmune disorders.
    Morshed SA; Parveen S; Leckman JF; Mercadante MT; Bittencourt Kiss MH; Miguel EC; Arman A; Yazgan Y; Fujii T; Paul S; Peterson BS; Zhang H; King RA; Scahill L; Lombroso PJ
    Biol Psychiatry; 2001 Oct; 50(8):566-77. PubMed ID: 11690591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibodies against human putamen in children with Tourette syndrome.
    Singer HS; Giuliano JD; Hansen BH; Hallett JJ; Laurino JP; Benson M; Kiessling LS
    Neurology; 1998 Jun; 50(6):1618-24. PubMed ID: 9633702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transplantation of rat neural stem cells reduces stereotypic behaviors in rats after intrastriatal microinfusion of Tourette syndrome sera.
    Liu X; Wang Y; Li D; Ju X
    Behav Brain Res; 2008 Jan; 186(1):84-90. PubMed ID: 17850895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors influencing diagnosis delay in children with Tourette syndrome.
    Shilon Y; Pollak Y; Benarroch F; Gross-Tsur V
    Eur J Paediatr Neurol; 2008 Sep; 12(5):398-400. PubMed ID: 18055232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Striatal microinfusion of Tourette syndrome and PANDAS sera: failure to induce behavioral changes.
    Loiselle CR; Lee O; Moran TH; Singer HS
    Mov Disord; 2004 Apr; 19(4):390-6. PubMed ID: 15077236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opsoclonus-myoclonus-ataxia syndrome in neuroblastoma: clinical outcome and antineuronal antibodies-a report from the Children's Cancer Group Study.
    Rudnick E; Khakoo Y; Antunes NL; Seeger RC; Brodeur GM; Shimada H; Gerbing RB; Stram DO; Matthay KK
    Med Pediatr Oncol; 2001 Jun; 36(6):612-22. PubMed ID: 11344492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropsychiatric aspects of Sydenham's chorea: a comprehensive review.
    Moore DP
    J Clin Psychiatry; 1996 Sep; 57(9):407-14. PubMed ID: 9746449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antineuronal antibodies in a group of children with obsessive-compulsive disorder and Tourette syndrome.
    Morer A; Lázaro L; Sabater L; Massana J; Castro J; Graus F
    J Psychiatr Res; 2008 Jan; 42(1):64-8. PubMed ID: 17113107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A transgenic model of comorbid Tourette's syndrome and obsessive-compulsive disorder circuitry.
    Nordstrom EJ; Burton FH
    Mol Psychiatry; 2002; 7(6):617-25, 524. PubMed ID: 12140785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Case reports and review of Tourette syndrome.
    Drigalla J; Puri V
    J Ky Med Assoc; 2007 Apr; 105(4):150-7. PubMed ID: 17494277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "Dude, you don't have Tourette's:" Tourette's syndrome, beyond the tics.
    Schapiro NA
    Pediatr Nurs; 2002; 28(3):243-6, 249-53. PubMed ID: 12087644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.